Angiotensin II (Giapreza)

Status:
Do Not Prescribe (DNP)
Decision Date:
September 2022
 

Comments

DNP: NICE TA859 - Angiotensin II for treating vasosuppressor-resistant hypotension caused by septic or distributive shock (Terminated appraisal). ICB commissioned. (Decision date - February 2023)

Do Not Prescribe (DNP) Drug Classifications

  • 5: Less cost-effective than current standard therapy

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app